• Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33504762).
  

PubMed=29563135; DOI=10.1158/1078-0432.CCR-17-1839
Dettling S., Stamova S., Warta R., Schnolzer M., Rapp C., Rathinasamy A., Reuss D., Pocha K., Roesch S., Jungk C., Warnken U., Eckstein V., Grabe N., Schramm C., Weigand M.A., von Deimling A., Unterberg A., Beckhove P., Herold-Mende C.
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as novel and frequent T-cell targets in human IDH-mutant glioma.
Clin. Cancer Res. 24:2951-2962(2018)

PubMed=33504762; DOI=10.1038/s41467-020-20752-6; PMCID=PMC7840755
Lita A., Pliss A., Kuzmin A., Yamasaki T., Zhang L.-M., Dowdy T., Burks C., de Val N., Celiku O., Ruiz-Rodado V., Nicoli E.-R., Kruhlak M.J., Andresson T., Das S., Yang C.-Z., Schmitt R., Herold-Mende C., Gilbert M.R., Prasad P.N., Larion M.
IDH1 mutations induce organelle defects via dysregulated phospholipids.
Nat. Commun. 12:614.1-614.16(2021)